MgSO4 Dosing for Severe Pre-eclampsia/Eclampsia
For severe pre-eclampsia or eclampsia, administer magnesium sulfate with a loading dose of 4 g IV over 5-15 minutes, followed by a maintenance infusion of 1 g/hour for 24 hours postpartum. 1, 2
Standard Dosing Regimen
Loading Dose
- 4 g IV over 5-15 minutes (preferred regimen from MAGPIE and Eclampsia trials) 3
- Alternative: 4-5 g IV in 250 mL D5W or normal saline may be infused 2
- The FDA label also describes a combined IV/IM approach: 4 g IV plus 10 g IM (5 g in each buttock) for total loading dose of 14 g 2
Maintenance Dose
- 1 g/hour continuous IV infusion for 24 hours 1
- Alternative: 1-2 g/hour by controlled infusion pump 2
- IM alternative: 4-5 g IM into alternate buttocks every 4 hours (Pritchard regimen) 2
Duration
- Continue for 24 hours postpartum 3
- Some evidence suggests women receiving ≥8 g before delivery may not benefit from continuing 24 hours postpartum, but this remains contentious and requires consideration of local eclampsia incidence 3
Recurrent Seizures
If seizures recur, give an additional 2-4 g IV over 5-15 minutes 1
Critical Monitoring Requirements
Before Each Dose, Verify:
- Patellar reflexes present (absent reflexes indicate toxicity at ~3.5-5 mmol/L) 1
- Respiratory rate ≥12-16 breaths/minute (respiratory depression occurs at 5-6.5 mmol/L) 4
- Urine output ≥25-30 mL/hour (magnesium is renally excreted) 1
Serum Magnesium Monitoring
- Not routinely needed unless toxicity suspected or renal impairment present 1
- Therapeutic range: 1.8-3.0 mmol/L (some sources cite 2.0-3.5 mmol/L) 4
- Target for seizure control: 6 mg/100 mL per FDA label 2
Dose Adjustments in Renal Impairment
In severe renal insufficiency, maximum dose is 20 grams over 48 hours with mandatory frequent serum magnesium monitoring 2
Rationale
- Magnesium is 90% renally excreted within 24 hours 4
- Renal dysfunction dramatically increases toxicity risk 5
- Even standard Pritchard regimens can cause toxicity with coexisting renal impairment 5
Management of Magnesium Toxicity
Signs of Toxicity (in order of severity):
- Loss of patellar reflexes (3.5-5 mmol/L)
- Respiratory depression/paralysis (5-6.5 mmol/L)
- Altered cardiac conduction (>7.5 mmol/L)
- Cardiac arrest (>12.5 mmol/L) 4
Treatment
Immediately give 10 mL of 10% calcium gluconate IV 1, 2
- Stop magnesium infusion
- Support ventilation as needed
- Consider hemodialysis in severe cases with renal impairment 5
Fetal Neuroprotection Dosing
While the question focuses on pre-eclampsia/eclampsia, the same dosing regimen (4 g loading, 1 g/hour maintenance) is used for fetal neuroprotection in preterm birth <32 weeks 6
Important Caveats
Fluid Management
- Restrict total fluids to 60-80 mL/hour to avoid pulmonary edema 3
- Monitor hourly urine output with bladder catheterization 1
Duration Limits
- Do not continue magnesium sulfate beyond 5-7 days as it causes fetal skeletal abnormalities (hypocalcemia, demineralization, osteopenia) 2
Drug Interactions
- Potentiates CNS depressants and neuromuscular blocking agents 2
- Use extreme caution with digitalized patients (can cause heart block) 2
- Avoid concurrent calcium channel blockers (risk of myocardial depression) 7
Rate of Administration
- Do not exceed 150 mg/minute IV except in severe eclampsia with active seizures 2
- Dilute to ≤20% concentration for IV infusion 2
Clinical Context
The ISSHP guidelines recommend that all preeclamptic women in low- and middle-income countries should receive MgSO4 given the favorable cost-benefit ratio (approximately 100 women need treatment to prevent 1 seizure) 3. In high-income settings with specialized centers, selective use in women with severe features is reasonable 3.
Severe features warranting MgSO4 include: severe hypertension (≥160/110 mmHg) with proteinuria ≥2-3+, or presence of neurological symptoms (headache, visual disturbances, clonus), or other organ dysfunction 3.